Chemistry

   

Evaluation of in Vitro Antibacterial Activity of Caralluma Lasiantha for Scientific Validation of Indian Traditional Medicine

Authors: Sireesha Malladi, Venkata Nadh Ratnakaram, K. Suresh Babu4, T. Pullaiah5

Caralluma lasiantha is used as a traditional medicine in India to heal body heat and inflammations. In order to find out a scientific validation for the Indian traditional knowledge, antibacterial activity of C. lasiantha extracts was studied against inflammation causing bacteria (viz., Staphylococcus aureus, Escherichia coli, Streptococcus Sp., Bacillus subtilis, Enterobacter aerogenes, Klebsiella pneumoniae) along with other Gram-positive and Gram-negative bacteria. Solvents with different polarity were used for extraction from dry roots and stems. Minimum inhibitory concentrations (MIC) were also studied. Differential antibacterial activity was exhibited by extracts and higher inhibition potential against Gram-positive bacteria was explained. The observed antibacterial activities were correlated with the chemical structures of phytochemicals present in C. lasiantha. Anti-inflammation activities are related to C. lasiantha extracts through their antibacterial activities.

Comments: 15 Pages. OK

Download: PDF

Submission history

[v1] 2019-05-19 02:49:37

Unique-IP document downloads: 0 times

Vixra.org is a pre-print repository rather than a journal. Articles hosted may not yet have been verified by peer-review and should be treated as preliminary. In particular, anything that appears to include financial or legal advice or proposed medical treatments should be treated with due caution. Vixra.org will not be responsible for any consequences of actions that result from any form of use of any documents on this website.

Add your own feedback and questions here:
You are equally welcome to be positive or negative about any paper but please be polite. If you are being critical you must mention at least one specific error, otherwise your comment will be deleted as unhelpful.

comments powered by Disqus